Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
Michael Rink(Marienkrankenhaus Hamburg), Sabine Riethdorf(Universität Hamburg), Sascha Ahyai(Medical University of Graz), Luis A. Kluth(Goethe University Frankfurt), Cornelia Coith(Universität Hamburg), Malgorzata Stoupiec(University Medical Center Hamburg-Eppendorf), Armin Soave(Universität Hamburg), Klaus Pantel(Universität Hamburg), Sarah Minner(Universität Hamburg), Shahrokh F. Shariat(Universitätszahnklinik Wien), Jens Hansen(Icahn School of Medicine at Mount Sinai), Martin Friedrich(Helios Klinikum Krefeld), Felix K.‐H. Chun(Universität Hamburg), Margit Fisch(University Medical Center Hamburg-Eppendorf), Roland Dahlem(University Medical Center Hamburg-Eppendorf)
Cited by 187
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
|British Journal of Cancer|2020|402
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells
|Developmental Cell|2018|328